Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model

Lingdan Chen, Cheng Fan, Yi Zhang, Mahinur Bakri, Hua Dong, Christophe Morisseau, Krishna Rao Maddipati, Pengcheng Luo, Cong Yi Wang, Bruce D. Hammock, Mong Heng Wang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Soluble epoxide hydrolase (sEH) is an enzyme involved in the metabolism of endogenous inflammatory and anti-apoptotic mediators. In the present study, we determined the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chemical-induced diabetes. STZ increased daily water intake and decreased visceral (spleen and pancreas) weight in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral weight. Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH. The beneficial effects of sEH inhibition were accompanied, after 2 and 4 weeks of initial administration, by improving glucose tolerance. In contrast, sEH inhibition did not affect insulin tolerance. Using LC/MS analysis, neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels. Western blot analysis showed that mouse cytochrome P450 (CYP) 2C enzymes are the major epoxygenases in islets. On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis. These studies provide pharmacological evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.

Original languageEnglish (US)
Pages (from-to)42-48
Number of pages7
JournalProstaglandins and Other Lipid Mediators
Volume104-105
DOIs
StatePublished - Jul 1 2013

Fingerprint

Epoxide Hydrolases
Streptozocin
Homeostasis
Glucose
Islets of Langerhans
Medical problems
Cytochrome P-450 Enzyme System
Drinking
Apoptosis
Chemical Models
Weights and Measures
Acids
Experimental Diabetes Mellitus
Water
Hyperglycemia
Metabolism
Pancreas
Spleen
Western Blotting
Pharmacology

Keywords

  • Apoptosis
  • CYP-derived eicosanoids
  • Glucose homeostasis
  • Islets

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. / Chen, Lingdan; Fan, Cheng; Zhang, Yi; Bakri, Mahinur; Dong, Hua; Morisseau, Christophe; Maddipati, Krishna Rao; Luo, Pengcheng; Wang, Cong Yi; Hammock, Bruce D.; Wang, Mong Heng.

In: Prostaglandins and Other Lipid Mediators, Vol. 104-105, 01.07.2013, p. 42-48.

Research output: Contribution to journalArticle

Chen, Lingdan ; Fan, Cheng ; Zhang, Yi ; Bakri, Mahinur ; Dong, Hua ; Morisseau, Christophe ; Maddipati, Krishna Rao ; Luo, Pengcheng ; Wang, Cong Yi ; Hammock, Bruce D. ; Wang, Mong Heng. / Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. In: Prostaglandins and Other Lipid Mediators. 2013 ; Vol. 104-105. pp. 42-48.
@article{63b94147b89e454ca2f740ab33f40dbe,
title = "Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model",
abstract = "Soluble epoxide hydrolase (sEH) is an enzyme involved in the metabolism of endogenous inflammatory and anti-apoptotic mediators. In the present study, we determined the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chemical-induced diabetes. STZ increased daily water intake and decreased visceral (spleen and pancreas) weight in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral weight. Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH. The beneficial effects of sEH inhibition were accompanied, after 2 and 4 weeks of initial administration, by improving glucose tolerance. In contrast, sEH inhibition did not affect insulin tolerance. Using LC/MS analysis, neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels. Western blot analysis showed that mouse cytochrome P450 (CYP) 2C enzymes are the major epoxygenases in islets. On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis. These studies provide pharmacological evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.",
keywords = "Apoptosis, CYP-derived eicosanoids, Glucose homeostasis, Islets",
author = "Lingdan Chen and Cheng Fan and Yi Zhang and Mahinur Bakri and Hua Dong and Christophe Morisseau and Maddipati, {Krishna Rao} and Pengcheng Luo and Wang, {Cong Yi} and Hammock, {Bruce D.} and Wang, {Mong Heng}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.prostaglandins.2012.12.001",
language = "English (US)",
volume = "104-105",
pages = "42--48",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model

AU - Chen, Lingdan

AU - Fan, Cheng

AU - Zhang, Yi

AU - Bakri, Mahinur

AU - Dong, Hua

AU - Morisseau, Christophe

AU - Maddipati, Krishna Rao

AU - Luo, Pengcheng

AU - Wang, Cong Yi

AU - Hammock, Bruce D.

AU - Wang, Mong Heng

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Soluble epoxide hydrolase (sEH) is an enzyme involved in the metabolism of endogenous inflammatory and anti-apoptotic mediators. In the present study, we determined the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chemical-induced diabetes. STZ increased daily water intake and decreased visceral (spleen and pancreas) weight in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral weight. Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH. The beneficial effects of sEH inhibition were accompanied, after 2 and 4 weeks of initial administration, by improving glucose tolerance. In contrast, sEH inhibition did not affect insulin tolerance. Using LC/MS analysis, neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels. Western blot analysis showed that mouse cytochrome P450 (CYP) 2C enzymes are the major epoxygenases in islets. On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis. These studies provide pharmacological evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.

AB - Soluble epoxide hydrolase (sEH) is an enzyme involved in the metabolism of endogenous inflammatory and anti-apoptotic mediators. In the present study, we determined the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chemical-induced diabetes. STZ increased daily water intake and decreased visceral (spleen and pancreas) weight in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral weight. Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH. The beneficial effects of sEH inhibition were accompanied, after 2 and 4 weeks of initial administration, by improving glucose tolerance. In contrast, sEH inhibition did not affect insulin tolerance. Using LC/MS analysis, neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels. Western blot analysis showed that mouse cytochrome P450 (CYP) 2C enzymes are the major epoxygenases in islets. On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis. These studies provide pharmacological evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.

KW - Apoptosis

KW - CYP-derived eicosanoids

KW - Glucose homeostasis

KW - Islets

UR - http://www.scopus.com/inward/record.url?scp=84879694969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879694969&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2012.12.001

DO - 10.1016/j.prostaglandins.2012.12.001

M3 - Article

C2 - 23247129

AN - SCOPUS:84879694969

VL - 104-105

SP - 42

EP - 48

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

ER -